Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
2.
Med Oral Patol Oral Cir Bucal ; 23(3): e308-e314, 2018 May 01.
Article in English | MEDLINE | ID: mdl-29680855

ABSTRACT

BACKGROUND: The study and identification of new biomarkers for periodontal disease, such as microRNAs (miRNAs), may give us more information about the location and severity of the disease and will serve as a basis for treatment planning and disease-monitoring. miRNAs are a group of small RNAs which are involved in gene regulation by binding to their messenger RNA target (mRNA). In this pilot study, the procedure for purifying miRNAs from gingival crevicular fluid (GCF) was, for the first time, described. In addition, the concentration of miRNAs in GCF was analyzed and compared between patients with moderate or severe chronic periodontitis (CP) and healthy controls. MATERIAL AND METHODS: GCF samples were collected from single-rooted teeth of patients with moderate or severe CP (n=9) and of healthy individuals (n=9). miRNAs were isolated from GCF using miRNeasy Serum/Plasma kit (Qiagen, CA. USA). Reverse transcription polymerase chain reaction (qRT-PCR) was used to determine the expression of a series of miRNAs candidates that are related to bone metabolism. The significance of differences in miRNA levels between both groups was determined using Mann-Whitney U test. RESULTS: The results from this pilot study indicate that miRNAs can be isolated from GCF. Six different miRNAs were analyzed (miR-671, miR-122, miR-1306, miR-27a, miR-223, miR-1226), but only miR-1226 showed statically significant differences between the CP group and healthy controls (p<0.05). This miRNA was downregulated in patients with CP. CONCLUSIONS: Within the limitations of the present study, it may be concluded that miR-1226 can be a promising biomarker for periodontal disease, adding relevant information to common clinical parameters used for diagnosis and prognosis of periodontitis.


Subject(s)
Chronic Periodontitis/diagnosis , Gingival Crevicular Fluid/chemistry , MicroRNAs/analysis , Adult , Biomarkers/analysis , Female , Humans , Male , Middle Aged , Pilot Projects
3.
Sci Rep ; 7(1): 10643, 2017 09 06.
Article in English | MEDLINE | ID: mdl-28878320

ABSTRACT

The aim of this study was to develop a novel method to detect circulating histones H3 and H2B in plasma based on multiple reaction monitoring targeted mass spectrometry and a multiple reaction monitoring approach (MRM-MS) for its clinical application in critical bacteriaemic septic shock patients. Plasma samples from 17 septic shock patients with confirmed bacteraemia and 10 healthy controls were analysed by an MRM-MS method, which specifically detects presence of histones H3 and H2B. By an internal standard, it was possible to quantify the concentration of circulating histones in plasma, which were significantly higher in patients, and thus confirmed their potential as biomarkers for diagnosing septic shock. After comparing surviving patients and non-survivors, a correlation was found between higher levels of circulating histones and unfavourable outcome. Indeed, histone H3 proved a more efficient and sensitive biomarker for septic shock prognosis. In conclusion, these findings suggest the accuracy of the MRM-MS technique and stable isotope labelled peptides to detect and quantify circulating plasma histones H2B and H3. This method may be used for early septic shock diagnoses and for the prognosis of fatal outcomes.


Subject(s)
Biomarkers , Histones/blood , Mass Spectrometry , Shock, Septic/blood , Adolescent , Adult , Aged , Aged, 80 and over , Bacteremia , Case-Control Studies , Humans , Mass Spectrometry/methods , Middle Aged , Peptides/blood , Prognosis , ROC Curve , Severity of Illness Index , Shock, Septic/diagnosis , Shock, Septic/etiology , Young Adult
4.
Sci Rep ; 7(1): 5237, 2017 07 12.
Article in English | MEDLINE | ID: mdl-28701783

ABSTRACT

MicroRNAs (miRNAs) are noncoding RNAs that contribute to gene expression modulation by regulating important cellular pathways. In this study, we used small RNA sequencing to identify a series of circulating miRNAs in blood samples taken from Friedreich's ataxia patients. We were thus able to develop a miRNA biomarker signature to differentiate Friedreich's ataxia (FRDA) patients from healthy people. Most research on FDRA has focused on understanding the role of frataxin in the mitochondria, and a whole molecular view of pathological pathways underlying FRDA therefore remains to be elucidated. We found seven differentially expressed miRNAs, and we propose that these miRNAs represent key mechanisms in the modulation of several signalling pathways that regulate the physiopathology of FRDA. If this is the case, miRNAs can be used to characterize phenotypic variation in FRDA and stratify patients' risk of cardiomyopathy. In this study, we identify miR-323-3p as a candidate marker for phenotypic differentiation in FRDA patients suffering from cardiomyopathy. We propose the use of dynamic miRNAs as biomarkers for phenotypic characterization and prognosis of FRDA.


Subject(s)
Biological Variation, Population , Biomarkers/blood , Cardiomyopathies/diagnosis , Friedreich Ataxia/complications , MicroRNAs/genetics , Adult , Aged , Cardiomyopathies/etiology , Cardiomyopathies/pathology , Case-Control Studies , Cell Proliferation , Cells, Cultured , Female , Follow-Up Studies , High-Throughput Nucleotide Sequencing , Humans , Male , MicroRNAs/blood , Middle Aged , Prognosis , Young Adult
5.
Clin Chim Acta ; 413(19-20): 1576-82, 2012 Oct 09.
Article in English | MEDLINE | ID: mdl-22664147

ABSTRACT

Epigenetics comprises the study of chemical modifications in the DNA and histones that regulates the gene expression or cellular phenotype. However, during the last decade this term has evolved after the elucidation of different mechanisms (microRNAs and nuclear organization of the chromosomes) involved in regulating gene expression. Epigenetics and the new designed technologies capable to analyze epigenetic changes (e.g., methylated DNA, miRNAs expression, post-translational modifications on histones among others) have disclosed an appealing scenario that will offer for the biomedical sciences new biomarkers for the study of neurodegenerative diseases, multifactorial complex diseases, rare diseases and cancer. Moreover, new technologies adapted for epigenetic studies will offer promising applications that in the next years will be common technologies in clinical laboratories. In this review we discuss epigenetic modifications used as possible biomarkers in several diseases. We also present the potential of methodologies to purify histones, and high throughput technologies as candidates to be set in clinical laboratories for their high potential analyzing epigenetic processes.


Subject(s)
Epigenesis, Genetic , Epigenomics , Histones/metabolism , MicroRNAs/genetics , Protein Processing, Post-Translational , Biomarkers/metabolism , DNA Methylation , Histones/genetics , Histones/isolation & purification , Humans , MicroRNAs/metabolism , Pathology, Molecular/instrumentation , Pathology, Molecular/methods , Pathology, Molecular/trends , Sequence Analysis, DNA
6.
Int J Sports Med ; 31(1): 5-9, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19885778

ABSTRACT

Blood doping improves physical performance in sport. This is the reason why the antidoping authorities subject athletes to blood tests. Plasma volume expanders are prohibited agents used to reduce an artificial increase in hematological values using different illegal practices. The aim of our study was to test whether desmopressin (DDAVP)-induced hemodilution would alter the concentration of hematological parameters used to detect blood doping in sports. This was an intra-subject crossover study. Venous blood samples were obtained from eight physically active males on two occasions. On the first occasion the subjects ingested 1.5 L of mineral water and 4.3 microg/kg of DDAVP. On the second occasion the subjects ingested 1.5 L of mineral water. The samples were analyzed for hematocrit, hemoglobin, reticulocytes, OFF Hr-Score, glucose, albumin, creatinine and total proteins. After treatment with DDAVP we found a significant decrease in the hematocrit, hemoglobin and in the OFF Hr-Score values. We also found a significant decrease in glucose, albumin, creatinine and total proteins concentration; however, in this case, all the values were significantly below the physiological levels. Treatment with DDAVP has a very effective hemodilution effect. We consider that this substance should be included in the WADA's prohibited list.


Subject(s)
Antidiuretic Agents/pharmacology , Deamino Arginine Vasopressin/pharmacology , Doping in Sports , Hemodilution/methods , Adult , Cross-Over Studies , Hematocrit , Hemoglobins/analysis , Humans , Male , Sports , Substance Abuse Detection/methods , Young Adult
7.
J Inorg Biochem ; 100(1): 70-9, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16313962

ABSTRACT

A new dinuclear copper(II) complex has been synthesised and structurally characterised: [Cu2(tz-ben)4] (Htz-ben = N-thiazol-2-yl-benzenesulfonamide). Its crystal structure, magnetic properties and electronic paramagnetic resonance (EPR) spectra were studied in detail. In the compound the metal centres are bridged by four non-linear triatomic NCN groups. The coordination geometry of the copper ions in the dinuclear entity is distorted square pyramidal (4+1). Two thiazole N and two sulfonamido N atoms occupy the equatorial positions and one sulfonamido O atom is in the axial position. Magnetic susceptibility data show a strong antiferromagnetic coupling, -2J = 114.1 cm(-1). The EPR spectra of a polycrystalline sample of compound has been obtained at the X- and Q-band frequencies at different temperatures. Above 20K the spectra are characteristic of S = 1 species with a zero field splitting parameter D = 0.4 cm(-1). The EPR parameters are discussed in terms of the known binuclear structures. The chemical nuclease ability of the title complex and that of the related [Cu2(tz-tol)4] compound (Htz-tol = N-thiazol-2-yl-toluenesulfonamide) is reported. The participation of hydroxyl radicals and a singlet oxygen-like entity in the DNA cleavage reaction has been deduced from the assays with radical oxygen scavengers.


Subject(s)
Copper/pharmacology , DNA/metabolism , Organometallic Compounds/chemical synthesis , Organometallic Compounds/pharmacology , Sulfonamides/pharmacology , Thiazoles/pharmacology , Copper/chemistry , Crystallography, X-Ray , DNA/chemistry , DNA/drug effects , Electron Spin Resonance Spectroscopy , Mass Spectrometry , Organometallic Compounds/chemistry , Spectrophotometry, Infrared , Sulfonamides/chemical synthesis , Sulfonamides/chemistry , Thiazoles/chemical synthesis , Thiazoles/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...